Sound Income Strategies’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
Other funds holding PSTV
Sound Income Strategies's PSTV Position: Q2 2026 in Review
Sound Income Strategies sold out of Plus Therapeutics (PSTV) in Q2 2026, closing a stake of 1 share — an estimated $4 sold.
Sound Income Strategies first reported a position in PSTV in Q4 2025 and held it in 2 quarters. The position peaked at $8 in Q4 2025. 2 funds tracked by Wall St. Rank hold PSTV as of Q2 2026.
- Sound Income Strategies reported no remaining Plus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Sound Income Strategies sold 1 Plus Therapeutics share in Q2 2026, an estimated $4.
- Sound Income Strategies first reported a position in Plus Therapeutics in Q4 2025 and held it in 2 quarters.
- Sound Income Strategies's Plus Therapeutics position peaked at $8 in Q4 2025.
- 2 funds tracked by Wall St. Rank held Plus Therapeutics as of Q2 2026.
Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.